+218.1%
MRNA vs COO
-24.0%
+242.2%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | COO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.7% | -4.2% | -3.8% |
| 7D | -12.1% | +0.5% | -12.6% | -12.2% |
| 30D | -1.3% | +14.2% | -15.5% | -6.8% |
| 3M | +250.9% | -18.2% | +269.1% | +284.1% |
| 6M | +343.0% | +5.3% | +337.7% | +331.2% |
| YTD | +657.4% | -23.6% | +681.0% | +756.7% |
| 1Y | +794.9% | -12.7% | +807.6% | +857.3% |
| 3Y | +218.1% | -24.2% | +242.3% | +232.2% |
| All | +218.1% | -24.0% | +242.2% | +232.2% |
Cumulative growth
Daily Returns
Daily percentage return beside COO.
Daily Out/Under-Performance
Portfolio return minus COO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × COO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded COO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling